Longer Duration of Treatment with ICIs Associated with a Higher Rate of Complete Response Among Patients with MMRd Cancers By Ogkologos - March 5, 2025 809 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a systematic review of published studies Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Spending Review 2020 – Steps in the right direction, but opportunities... November 25, 2020 Medical Cannabis Formulation May Be Capable of Killing Breast Cancer Cells,... May 21, 2021 Making Important Decisions During Cancer: A Survivor’s Story October 26, 2021 Oncology Dietitians Don’t Usually Inquire About Food Insecurity in Cancer Patients,... February 12, 2022 Load more HOT NEWS Reunión anual de la American Society of Clinical Oncology de 2021:... FDA Grants Accelerated Approval to Ponatinib with Chemotherapy for Newly Diagnosed... Kids Facing Difficult Medical Diagnoses Take Train To The ‘North Pole’... 24-Year-Old Diagnosed With Breast Cancer After Doctors Said Her Chest Was...
